Al­lied with Roche and As­traZeneca, 4D Mol­e­c­u­lar bags $90M round for its gene ther­a­py pipeline work

Gene ther­a­py re­mains one of the hottest fields in biotech.

Right on the heels of strik­ing col­lab­o­ra­tion deals with Roche and As­traZeneca, 4D Mol­e­c­u­lar Ther­a­peu­tics …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER